Company: DNLI
Filing Date: 2025-04-17
Form Type: DEF 14A
Source: 0001714899-25-000087
Chunk: 67

Company: Denali Therapeutics Inc.
Filing Date: 2025-04-17
Form: DEF 14A
Chunk 67
---
0        |     |                                              $32,742,847 |     |   $103,131,232 |     | $—             |     |      $3,581,134 |     | $—             |     |  $139,455,213 |

In accordance with the relevant rules, the fair values of unvested and outstanding equity awards to our PEO were remeasured as of the end of each fiscal year, and as of each vesting date, during the years displayed in the table above. RSUs were valued at fair value, determined as the closing price of the Company's common stock on each measurement date. To value the performance and market contingent stock options as of each measurement date, the Company used a lattice model with a Monte Carlo simulation. This valuation methodology utilized the estimated fair value of the Company’s common stock on grant date and several key assumptions, including expected volatility of the Company’s stock price based on comparable public companies, risk-free rates of return and expected dividend yield. For all other stock options, the fair values as of each measurement date were determined using the Black-Scholes model, with assumptions and methodologies regarding volatility, dividend yield, and risk-free rates as outlined in the table below. The expected life of options as of each measurement date is estimated based on consideration of consistency with the original valuation assumptions for the grant, the circumstances of the grant at the measurement date, and other relevant factors under US GAAP.

|                          |     | Year Ended December 31, 
 2024                    |     | 2023           |     | 2022           |     | 2021           |     | 2020           |
|:-------------------------|:----|:------------------------|:----|:---------------|:----|:---------------|:----|:---------------|:----|:---------------|
| Expected term (in years) |     | 3.10-5.47               |     | 3.65-5.47      |     | 3.65-5.47      |     | 3.65-5.47      |     | 3.77-5.53      |
| Volatility               |     | 61.33% -69.74%          |     | 66.22% -70.75% |     | 63.50% -67.73% |     | 57.46% -63.34% |     | 63.35% -78.